1. Home
  2. TKNO vs CLDT Comparison

TKNO vs CLDT Comparison

Compare TKNO & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • CLDT
  • Stock Information
  • Founded
  • TKNO 1996
  • CLDT 2009
  • Country
  • TKNO United States
  • CLDT United States
  • Employees
  • TKNO N/A
  • CLDT N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • CLDT Real Estate Investment Trusts
  • Sector
  • TKNO Health Care
  • CLDT Real Estate
  • Exchange
  • TKNO Nasdaq
  • CLDT Nasdaq
  • Market Cap
  • TKNO 256.9M
  • CLDT 374.7M
  • IPO Year
  • TKNO 2021
  • CLDT 2010
  • Fundamental
  • Price
  • TKNO $4.35
  • CLDT $7.61
  • Analyst Decision
  • TKNO
  • CLDT Strong Buy
  • Analyst Count
  • TKNO 0
  • CLDT 2
  • Target Price
  • TKNO N/A
  • CLDT $10.75
  • AVG Volume (30 Days)
  • TKNO 224.0K
  • CLDT 264.3K
  • Earning Date
  • TKNO 08-07-2025
  • CLDT 08-06-2025
  • Dividend Yield
  • TKNO N/A
  • CLDT 4.72%
  • EPS Growth
  • TKNO N/A
  • CLDT N/A
  • EPS
  • TKNO N/A
  • CLDT 0.03
  • Revenue
  • TKNO $38,923,000.00
  • CLDT $310,140,000.00
  • Revenue This Year
  • TKNO $9.52
  • CLDT N/A
  • Revenue Next Year
  • TKNO $15.20
  • CLDT $0.45
  • P/E Ratio
  • TKNO N/A
  • CLDT $277.86
  • Revenue Growth
  • TKNO 11.40
  • CLDT N/A
  • 52 Week Low
  • TKNO $4.00
  • CLDT $5.83
  • 52 Week High
  • TKNO $10.37
  • CLDT $10.00
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 43.35
  • CLDT 63.27
  • Support Level
  • TKNO $4.22
  • CLDT $7.57
  • Resistance Level
  • TKNO $4.94
  • CLDT $7.82
  • Average True Range (ATR)
  • TKNO 0.29
  • CLDT 0.16
  • MACD
  • TKNO -0.00
  • CLDT 0.06
  • Stochastic Oscillator
  • TKNO 16.75
  • CLDT 76.92

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: